Akebia Therapeutics to Report First Quarter 2026 Financial Results and Discuss Recent Business Highlights
Go back to Akebia Therapeutics to Report First Quarter 2026 Financial Results and Discuss Recent Business Highlights| AKEBIA THERAPEUTICS (NASDAQ: AKBA) | Delayed: 1.12 +0.03 (2.75%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $1.09 | 52 Week High | $13.20 | |||
| Open | $1.09 | 52 Week Low | $7.00 | |||
| Day High | $1.14 | P/E | N/A | |||
| Day Low | $1.09 | EPS | $0.00 | |||
| Volume | 1,643,315 | |||||
